Literature DB >> 25016196

Next generation MRD.

Christopher S Hourigan1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25016196      PMCID: PMC4209896          DOI: 10.1016/j.bbmt.2014.07.002

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN: 1083-8791            Impact factor:   5.742


× No keyword cloud information.
  16 in total

1.  High-throughput sequencing detects minimal residual disease in acute T lymphoblastic leukemia.

Authors:  David Wu; Anna Sherwood; Jonathan R Fromm; Stuart S Winter; Kimberly P Dunsmore; Mignon L Loh; Harvey A Greisman; Daniel E Sabath; Brent L Wood; Harlan Robins
Journal:  Sci Transl Med       Date:  2012-05-16       Impact factor: 17.956

Review 2.  Clinical significance of minimal residual disease in patients with acute leukaemia undergoing haematopoietic stem cell transplantation.

Authors:  Dario Campana; Wing Leung
Journal:  Br J Haematol       Date:  2013-05-09       Impact factor: 6.998

3.  Massive evolution of the immunoglobulin heavy chain locus in children with B precursor acute lymphoblastic leukemia.

Authors:  Charles Gawad; Francois Pepin; Victoria E H Carlton; Mark Klinger; Aaron C Logan; David B Miklos; Malek Faham; Gary Dahl; Norman Lacayo
Journal:  Blood       Date:  2012-08-28       Impact factor: 22.113

Review 4.  Minimal residual disease in acute myeloid leukaemia.

Authors:  Christopher S Hourigan; Judith E Karp
Journal:  Nat Rev Clin Oncol       Date:  2013-06-25       Impact factor: 66.675

5.  Flow cytometry and IG/TCR quantitative PCR for minimal residual disease quantitation in acute lymphoblastic leukemia: a French multicenter prospective study on behalf of the FRALLE, EORTC and GRAALL.

Authors:  R Garand; K Beldjord; H Cavé; C Fossat; I Arnoux; V Asnafi; Y Bertrand; M-L Boulland; C Brouzes; E Clappier; E Delabesse; T Fest; F Garnache-Ottou; F Huguet; M-C Jacob; E Kuhlein; S Marty-Grès; A Plesa; N Robillard; M Roussel; J Tkaczuk; H Dombret; E Macintyre; N Ifrah; M C Béné; A Baruchel
Journal:  Leukemia       Date:  2012-08-16       Impact factor: 11.528

6.  Deep-sequencing approach for minimal residual disease detection in acute lymphoblastic leukemia.

Authors:  Malek Faham; Jianbiao Zheng; Martin Moorhead; Victoria E H Carlton; Patricia Stow; Elaine Coustan-Smith; Ching-Hon Pui; Dario Campana
Journal:  Blood       Date:  2012-10-16       Impact factor: 22.113

7.  Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia.

Authors:  Timothy J Ley; Christopher Miller; Li Ding; Benjamin J Raphael; Andrew J Mungall; A Gordon Robertson; Katherine Hoadley; Timothy J Triche; Peter W Laird; Jack D Baty; Lucinda L Fulton; Robert Fulton; Sharon E Heath; Joelle Kalicki-Veizer; Cyriac Kandoth; Jeffery M Klco; Daniel C Koboldt; Krishna-Latha Kanchi; Shashikant Kulkarni; Tamara L Lamprecht; David E Larson; Ling Lin; Charles Lu; Michael D McLellan; Joshua F McMichael; Jacqueline Payton; Heather Schmidt; David H Spencer; Michael H Tomasson; John W Wallis; Lukas D Wartman; Mark A Watson; John Welch; Michael C Wendl; Adrian Ally; Miruna Balasundaram; Inanc Birol; Yaron Butterfield; Readman Chiu; Andy Chu; Eric Chuah; Hye-Jung Chun; Richard Corbett; Noreen Dhalla; Ranabir Guin; An He; Carrie Hirst; Martin Hirst; Robert A Holt; Steven Jones; Aly Karsan; Darlene Lee; Haiyan I Li; Marco A Marra; Michael Mayo; Richard A Moore; Karen Mungall; Jeremy Parker; Erin Pleasance; Patrick Plettner; Jacquie Schein; Dominik Stoll; Lucas Swanson; Angela Tam; Nina Thiessen; Richard Varhol; Natasja Wye; Yongjun Zhao; Stacey Gabriel; Gad Getz; Carrie Sougnez; Lihua Zou; Mark D M Leiserson; Fabio Vandin; Hsin-Ta Wu; Frederick Applebaum; Stephen B Baylin; Rehan Akbani; Bradley M Broom; Ken Chen; Thomas C Motter; Khanh Nguyen; John N Weinstein; Nianziang Zhang; Martin L Ferguson; Christopher Adams; Aaron Black; Jay Bowen; Julie Gastier-Foster; Thomas Grossman; Tara Lichtenberg; Lisa Wise; Tanja Davidsen; John A Demchok; Kenna R Mills Shaw; Margi Sheth; Heidi J Sofia; Liming Yang; James R Downing; Greg Eley
Journal:  N Engl J Med       Date:  2013-05-01       Impact factor: 91.245

8.  Detection of minimal residual disease in B lymphoblastic leukemia by high-throughput sequencing of IGH.

Authors:  David Wu; Ryan O Emerson; Anna Sherwood; Mignon L Loh; Anne Angiolillo; Bryan Howie; Jennifer Vogt; Mark Rieder; Ilan Kirsch; Christopher Carlson; David Williamson; Brent L Wood; Harlan Robins
Journal:  Clin Cancer Res       Date:  2014-06-26       Impact factor: 12.531

9.  Treating childhood acute lymphoblastic leukemia without cranial irradiation.

Authors:  Ching-Hon Pui; Dario Campana; Deqing Pei; W Paul Bowman; John T Sandlund; Sue C Kaste; Raul C Ribeiro; Jeffrey E Rubnitz; Susana C Raimondi; Mihaela Onciu; Elaine Coustan-Smith; Larry E Kun; Sima Jeha; Cheng Cheng; Scott C Howard; Vickey Simmons; Amy Bayles; Monika L Metzger; James M Boyett; Wing Leung; Rupert Handgretinger; James R Downing; William E Evans; Mary V Relling
Journal:  N Engl J Med       Date:  2009-06-25       Impact factor: 91.245

10.  Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing.

Authors:  Li Ding; Timothy J Ley; David E Larson; Christopher A Miller; Daniel C Koboldt; John S Welch; Julie K Ritchey; Margaret A Young; Tamara Lamprecht; Michael D McLellan; Joshua F McMichael; John W Wallis; Charles Lu; Dong Shen; Christopher C Harris; David J Dooling; Robert S Fulton; Lucinda L Fulton; Ken Chen; Heather Schmidt; Joelle Kalicki-Veizer; Vincent J Magrini; Lisa Cook; Sean D McGrath; Tammi L Vickery; Michael C Wendl; Sharon Heath; Mark A Watson; Daniel C Link; Michael H Tomasson; William D Shannon; Jacqueline E Payton; Shashikant Kulkarni; Peter Westervelt; Matthew J Walter; Timothy A Graubert; Elaine R Mardis; Richard K Wilson; John F DiPersio
Journal:  Nature       Date:  2012-01-11       Impact factor: 49.962

View more
  3 in total

1.  Posttransplantation MRD monitoring in patients with AML by next-generation sequencing using DTA and non-DTA mutations.

Authors:  Michael Heuser; Bennet Heida; Konstantin Büttner; Clara Philine Wienecke; Katrin Teich; Carolin Funke; Maximilian Brandes; Piroska Klement; Alessandro Liebich; Martin Wichmann; Blerina Neziri; Anuhar Chaturvedi; Arnold Kloos; Konstantinos Mintzas; Verena I Gaidzik; Peter Paschka; Lars Bullinger; Walter Fiedler; Albert Heim; Wolfram Puppe; Jürgen Krauter; Konstanze Döhner; Hartmut Döhner; Arnold Ganser; Michael Stadler; Lothar Hambach; Razif Gabdoulline; Felicitas Thol
Journal:  Blood Adv       Date:  2021-05-11

Review 2.  Advancing the Minimal Residual Disease Concept in Acute Myeloid Leukemia.

Authors:  Peter Hokland; Hans B Ommen; Matthew P Mulé; Christopher S Hourigan
Journal:  Semin Hematol       Date:  2015-04-07       Impact factor: 3.851

3.  A multigene array for measurable residual disease detection in AML patients undergoing SCT.

Authors:  M Goswami; K S McGowan; K Lu; N Jain; J Candia; N F Hensel; J Tang; K R Calvo; M Battiwalla; A J Barrett; C S Hourigan
Journal:  Bone Marrow Transplant       Date:  2015-02-09       Impact factor: 5.483

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.